{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:51:01Z","timestamp":1784328661075,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2434,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hydralazine and nitrate combination was the first treatment that showed improved survival of patients with heart failure with reduced left ventricular ejection fraction (HFREF) in the Vasodilator Heart Failure Trial (V-HeFT trial) in 1986. This showed a 34% reduction of mortality at 2 years of follow-up in patients with advanced heart failure (New York Heart Association Class IV). The angiotensin-converting enzyme inhibitor (ACEi), beta-blockers, mineralocorticoid receptor antagonists, and most recently sacubitril\u2013valsartan have superseded the combination of hydralazine and nitrates. However, the latter combination does have a place bridging the survival gap of Black patients with HFREF when added to their standard therapy. This was demonstrated in the African-American Heart Failure Trial (A-HeFT trial) in 2004 when the risk reduction in the Black patients was 43% compared with that in the placebo. This combination may have a potential use in patients with contraindications to the use of ACEi, angiotensin receptor blockers, and sacubitril\u2013valsartan. This is suggested by both the European Society of Cardiology (ESC) Guidelines and the guidelines of the National Institute for Health and Care Excellence (NICE). In this perspective, the role of the combination of hydralazine and nitrates in the treatment of HFREF is reviewed through a synopsis of the evidence base consisting of three randomized controlled studies, several further analyses of subgroups within those trials, a systemic review, and two large observational studies of registry cohorts. The place of the combination in the treatment cascades proposed by heart failure guidelines of the ESC and NICE is explored. This perspective is to remind us of their appropriate roles, particularly given the findings of underuse of this combination in people of African ancestry in Europe.<\/jats:p>","DOI":"10.1002\/ehf2.12459","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:25:26Z","timestamp":1558607126000},"page":"878-883","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hydralazine and Nitrates in the Treatment of Heart Failure with Reduced Ejection Fraction"],"prefix":"10.1093","volume":"6","author":[{"given":"Abdallah","family":"Al-Mohammad","sequence":"first","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"2026012115092231300_ehf212459-bib-0001","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(72)90460-6","article-title":"Improved left ventricular function during nitroprusside infusion in acute myocardial infarction","volume":"1","author":"Franciosa","year":"1972","journal-title":"Lancet"},{"key":"2026012115092231300_ehf212459-bib-0002","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure","volume":"314","year":"1986","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0003","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure","volume":"316","author":"The consensus trial study group","year":"1987","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0004","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine\u2013isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials","volume":"5","author":"Carson","year":"1999","journal-title":"J Card Fail"},{"key":"2026012115092231300_ehf212459-bib-0007","first-page":"IV","article-title":"Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate","volume":"75","author":"Cohn","year":"1987","journal-title":"Circulation"},{"key":"2026012115092231300_ehf212459-bib-0008","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction","volume":"344","author":"Exner","year":"2001","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0009","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012115092231300_ehf212459-bib-0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2015.05.160","article-title":"Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systemic review","volume":"196","author":"Farag","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026012115092231300_ehf212459-bib-0011","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115092231300_ehf212459-bib-0012","doi-asserted-by":"crossref","first-page":"k3646","DOI":"10.1136\/bmj.k3646","article-title":"Chronic heart failure in adults: summary of updated NICE guidance","volume":"362","author":"Real","year":"2018","journal-title":"BMJ"},{"key":"2026012115092231300_ehf212459-bib-0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002444","article-title":"Clinical effectiveness of hydralazine-isosorbide dinitrate therapy in patients with heart failure and reduced ejection fraction: findings from the GWTG-HF Registry","volume":"9","author":"Khazanie","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012115092231300_ehf212459-bib-0014","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jchf.2017.04.008","article-title":"Clinical effectiveness of hydralazine\u2013isosorbide dinitrate in African-American patients with heart failure","volume":"5","author":"Ziaeian","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012115092231300_ehf212459-bib-0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ehf2.12421","article-title":"Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey","volume":"6","author":"Brewster","year":"2019","journal-title":"ESC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12459","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12459","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/878\/66136699\/eschf_6_4_878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/4\/878\/66136699\/eschf_6_4_878.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:12:06Z","timestamp":1769026326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/4\/878\/8403554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,5,22]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12459","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"2018-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}